anonymous
Guest
anonymous
Guest
Soooo, just wondering …
Is Lilly’s $15B stock buyback a sign of confidence in the company?
Or an admission that what comes next ain’t so great and we’re willing to prop up the value of leadership’s incentive awards in way necessary?
Is Lilly’s $15B stock buyback a sign of confidence in the company?
Or an admission that what comes next ain’t so great and we’re willing to prop up the value of leadership’s incentive awards in way necessary?